NEUVIS - Trademark Details
Status: 641 - Non-Final Action - Mailed
Image for trademark with serial number 79268366
Serial Number
79268366
Word Mark
NEUVIS
Status
641 - Non-Final Action - Mailed
Status Date
2022-01-21
Filing Date
2019-07-31
Mark Drawing
4000 - Standard character mark Typeset
Attorney Name
Law Office Assigned Location Code
O20
Employee Name
DANTZLER, LAUREN ALEXA
Statements
Goods and Services
Pharmaceutical preparations, namely, pharmaceutical preparations for prevention, management or treatment of inflammatory disorders, neurological disorders, psychiatric disorders, malignancy, immune disorders, metabolic disorders, infectious diseases, gastrointestinal disorders, cardiovascular disorders, cancer, pain; Pharmaceutical preparations derived from natural sources namely, plants, herbs, and flowers for the treatment of seizures, nausea, vomiting, inflammation, arthritis, autoimmune disorders, cancer, diabetes, endometriosis, dementia, Alzheimer's disease, Parkinson's disease, gastrointestinal disorder, inflammatory bowel disease, Crohn's disease, ulcerative colitis, glaucoma, hypertension, anxiety, depression, stress, mood disorder, substance abuse, addiction, insomnia, sleep disorder, fatigue, eating disorder, appetite modification, muscle spasms, multiple sclerosis, muscle tension, tension, behavior modification, schizophrenia, bi-polar disorder, pain; Veterinary preparations derived from natural sources namely, plants, herbs, and flowers for the treatment of seizures, nausea, vomiting, inflammation, arthritis, autoimmune disorders, cancer, diabetes, glaucoma, anxiety, appetite modification, muscle spasms, behavioural modification, pain; Plant extracts for medical, pharmaceutical and veterinary use; Biochemical and biological products, in the nature of terpenophenolics, terpenoids and flavones for medical and pharmaceutical use for the treatment of seizures, nausea, vomiting, inflammation, arthritis, autoimmune disorders, cancer, diabetes, endometriosis, dementia, Alzheimer's disease, Parkinson's disease, gastrointestinal disorder, inflammatory bowel disease, Crohn's, ulcerative colitis, glaucoma, hypertension, anxiety, depression, stress, mood disorder, substance abuse, addiction, insomnia, sleep disorder, fatigue, eating disorder, appetite modification, muscle spasms, multiple sclerosis, muscle tension, tension, behavioural modification, schizophrenia, bi-polar, pain; Biochemical and biological products, namely, terpenophenolics, terpenoids and flavones for veterinary use for the treatment of seizures, nausea, vomiting, inflammation, arthritis, autoimmune disorders, cancer, diabetes, glaucoma, anxiety, appetite modification, muscle spasms, behavioural modification, pain; Chemical preparations for medical and pharmaceutical use for the treatment of seizures, nausea, vomiting, inflammation, arthritis, autoimmune disorders, cancer, diabetes, endometriosis, dementia, Alzheimer's disease, Parkinson's disease, gastrointestinal disorder, inflammatory bowel disease, Crohn's, ulcerative colitis, glaucoma, hypertension, anxiety, depression, stress, mood disorder, substance abuse, addiction, insomnia, sleep disorder, fatigue, eating disorder, appetite modification, muscle spasms, multiple sclerosis, muscle tension, tension, behavioural modification, schizophrenia, bi-polar, pain; Chemical preparations for veterinary use for the treatment of seizures, nausea, vomiting, inflammation, arthritis, autoimmune disorders, cancer, diabetes, glaucoma, anxiety, appetite modification, muscle spasms, behavioural modification, pain; Chemical products, namely, aminoalkylindoles, 1,5-diarylpyrazoles, quinolines, arylsulfonamides, eicosanoids for medical and pharmaceutical use for the treatment of seizures, nausea, vomiting, inflammation, arthritis, autoimmune disorders, cancer, diabetes, endometriosis, dementia, Alzheimer's disease, Parkinson's disease, gastrointestinal disorder, inflammatory bowel disease, Crohn's, ulcerative colitis, glaucoma, hypertension, anxiety, depression, stress, mood disorder, substance abuse, addiction, insomnia, sleep disorder, fatigue, eating disorder, appetite modification, muscle spasms, multiple sclerosis, muscle tension, tension, behavioural modification, schizophrenia, bi-polar, pain; Chemical products, namely, aminoalkylindoles, 1,5-diarylpyrazoles, quinolines, arylsulfonamides, eicosanoids for veterinary use for the treatment of seizures, nausea, vomiting, inflammation, arthritis, autoimmune disorders, cancer, diabetes, glaucoma, anxiety, appetite modification, muscle spasms, behavioural modification, pain; Analgesic preparations; Anti-inflammatory preparations; Anti-microbial preparations for inhibiting microbiological growth and infection in medical and veterinary situations; Anti-nauseants treatment preparations; Anti-spasmodics; Anticonvulsants; Appetite stimulant preparations for medical purposes; Nausea medications, namely, nausea treatment preparations
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-10-04
Primary Code
005
Current Trademark Owners
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Charles G. Zug
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1489529
International Registration Date
2019-07-31
International Publication Date
2019-09-26
International Renewal Date
2029-07-31
Auto Protection Date
2021-03-26
International Status
001 - Request for extension of protection established
International Status Date
2019-09-26
Priority Claimed In
True
Priority Claimed Date
2019-03-11
First Refusal In
True
Trademark Events
Event DateEvent Description
2019-09-26SN ASSIGNED FOR SECT 66A APPL FROM IB
2019-10-04NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2019-10-08APPLICATION FILING RECEIPT MAILED
2019-10-25ASSIGNED TO EXAMINER
2019-11-05ASSIGNED TO EXAMINER
2020-07-17ASSIGNED TO EXAMINER
2020-07-24NON-FINAL ACTION WRITTEN
2020-07-25NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2020-08-28REFUSAL PROCESSED BY MPU
2020-09-09NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2020-09-26REFUSAL PROCESSED BY IB
2021-03-03NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
2021-03-03NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2021-03-09TEAS RESPONSE TO OFFICE ACTION RECEIVED
2021-03-09CORRESPONDENCE RECEIVED IN LAW OFFICE
2021-03-09TEAS/EMAIL CORRESPONDENCE ENTERED
2021-03-20NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
2021-04-14NON-FINAL ACTION WRITTEN
2021-04-14NON-FINAL ACTION E-MAILED
2021-04-14NOTIFICATION OF NON-FINAL ACTION E-MAILED
2021-10-14TEAS RESPONSE TO OFFICE ACTION RECEIVED
2021-10-14CORRESPONDENCE RECEIVED IN LAW OFFICE
2021-10-15TEAS/EMAIL CORRESPONDENCE ENTERED
2022-01-21NON-FINAL ACTION WRITTEN
2022-01-21NON-FINAL ACTION E-MAILED
2022-01-21NOTIFICATION OF NON-FINAL ACTION E-MAILED